Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Glia. 2005 Jun;50(4):389-97.

Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy.

Author information

  • Neural and Vascular Biology, Ordway Research Institute, Albany, New York 12208, USA. hkimelberg@ordwayresearch.org

Abstract

In this viewpoint article, I summarize data showing that the astrocytic swelling that occurs early after the acute CNS pathologies ischemia and traumatic brain injury is damaging. We have proposed that one reason may be the release of excitatory amino acids (EAA) via volume-activated anion channels (VRACs) that are activated by such swelling. This release could be a target for therapy, which could involve blocking the astrocytic swelling or the release mechanisms. The transport mechanisms likely causing the early astrocytic swelling are therefore summarized. In terms of targeting the release mechanisms, we have found a potent inhibitor of VRACs, tamoxifen, to be strongly neuroprotective in focal ischemia with a therapeutic window of 3 h after initiation of the ischemia. The question, however, of whether neuroprotection by tamoxifen can be solely attributed to VRAC inhibition in astrocytes has yet to be resolved.

Copyright 2005 Wiley-Liss, Inc.

PMID:
15846797
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk